Bullish
$MSFT COVID-19 CURE INCOMING: "What my company is doing is adapting antibodies to recognize and neutralize the novel coronavirus. So this would ... [be] sort of skipping what a vaccine does," Glanville said. "Instead of giving you a vaccine and waiting for it to produce an immune response, we just give you those antibodies right away.”